1887
Editorial Open Access
Like 0
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2022.27.47.2200893
2022-11-24
2024-05-20
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2022.27.47.2200893
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/27/47/eurosurv-27-47-1.html?itemId=/content/10.2807/1560-7917.ES.2022.27.47.2200893&mimeType=html&fmt=ahah

References

  1. European Commission. European Health Union: building a stronger EU health response. Brussels: European Commission; 24 Oct 2022. Press release. Available from: https://ec.europa.eu/commission/presscorner/detail/en/IP_22_6363
  2. European Commission. Regulation (EU) 2022/123 of the European Parliament and of the Council of 25 January 2022 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices. Official Journal of the European Union. Luxembourg: Publications Office of the European Union. 31.1.2022:L 20. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32022R0123
  3. Health Emergency Preparedness and Response Authority (HERA). Health Union: Identifying top 3 priority health targets. Brussels: HERA; 2022. Available from: https://health.ec.europa.eu/document/download/18c127ce-da4b-4e4e-a27c-f7b93efb2980_en?filename=hera_factsheet_health-threat_mcm.pdf
  4. European Commission. European Health Union: building a stronger EU health response. Brussels: European Commission; 2022. Available from: https://ec.europa.eu/commission/presscorner/detail/en/ip_22_6363
  5. VACCELERATE. VACCELERATE. Cologne: VACCELERATE; 2022. Available from: https://vaccelerate.eu/
  6. EU-RESPONSE. Home - EU-Response. Paris: National Institute of Health and Medical Research. Available from: https://eu-response.eu/
  7. European Medicines Agency (EMA). Emergency Task Force (ETF). Amsterdam: EMA; 2022. Available from: https://www.ema.europa.eu/en/committees/working-parties-other-groups/emergency-task-force-etf
  8. European Commission. Communication from the Commission to the European Parliament, the European Council, the Council and the European Investment Bank. EU Strategy for COVID-19 vaccines. Brussels: European Commission. 17 Jun 2020. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52020DC0245&from=EN
  9. European Centre for Disease Prevention and Control (ECDC). Epidemiological update: Monkeypox outbreak. Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/en/news-events/epidemiological-update-monkeypox-outbreak
  10. European Commission. European Health Union: HERA secures up to 2 million doses of the monkeypox vaccine. Brussels: European Commission; 2022. Available from: https://ec.europa.eu/commission/presscorner/detail/en/ip_22_6766
  11. European Medicines Agency (EMA). Monkeypox: Recommendations on use of monkeypox vaccine. Amsterdam: EMA; 2022. Available from: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/monkeypox#recommendations-on-use-of-monkeypox-vaccine-section
  12. European Centre for Disease Prevention and Control (ECDC). High monkeypox vaccine acceptance among male users of smartphone-based online gay-dating apps in Europe. Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/en/news-events/high-monkeypox-vaccine-acceptance-among-male-users-smartphone-based-online-gay-dating
  13. World Health Organization Regional Office for Europe (WHO/Europe). WHO Director-General declares the ongoing monkeypox outbreak a Public Health Emergency of International Concern. Copenhagen: WHO/Europe; 23 Jul 2022. Available from: https://www.who.int/europe/news/item/23-07-2022-who-director-general-declares-the-ongoing-monkeypox-outbreak-a-public-health-event-of-international-concern#:~:text=On%20July%2023%2C%20the%20WHO%20Director-General%20declared%20the,reported%20cases%20are%20in%20the%20WHO%20European%20Region.
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error